SCHEMBL24701408

SCHEMBL24701408

N#Cc1c(-c2ccccc2)c(-n2c3ccccc3c3ccc4oc5ccccc5c4c32)c(-n2c3ccccc3c3ccc4oc5ccccc5c4c32)c(C#N)c1-n1c2ccccc2c2ccc3oc4ccccc4c3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.38
▸ HTR3A P46098 1/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ PDE9A O76083 2/20 0.32
▸ PDE1C Q14123 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ NCOA3 Q9Y6Q9 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ CHRM2 P08172 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25765881 0.94 ADORA2A (0.38) ADORA2AHTR3AALDH1A1HSD17B10ALOX15
SCHEMBL27019799 0.94 ADORA2A (0.39) ADORA2AHTR3AALDH1A1HSD17B10ALOX15
SCHEMBL24701574 0.94 ADORA2A (0.40) ADORA2AHTR3AALDH1A1HSD17B10ALOX15
SCHEMBL24701410 0.92 ADORA2A (0.39) ADORA2AHTR3AALDH1A1HSD17B10ALOX15
SCHEMBL24701409 0.91 ADORA2A (0.40) ADORA2AHTR3AALDH1A1HSD17B10ALOX15
SCHEMBL24871915 0.90 ALDH1A1 (0.33) ADORA2AALDH1A1HSD17B10KDM4EMAPT
SCHEMBL24871916 0.89 ALDH1A1 (0.35) ADORA2AALDH1A1HSD17B10KDM4ELMNA
SCHEMBL24700872 0.88 ALDH1A1 (0.33) ADORA2AALDH1A1KDM4EMAPTHPGD
SCHEMBL23351627 0.88 ALDH1A1 (0.33) ADORA2AALDH1A1KDM4EMAPTHPGD
SCHEMBL23351736 0.88 ALDH1A1 (0.33) ADORA2AALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388991-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388991-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LSM12, TCF12, OR10J3 ADORA2A 4610/4885HTR3A 4789/4885ALDH1A1 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback